JP2020128429A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020128429A5 JP2020128429A5 JP2020096003A JP2020096003A JP2020128429A5 JP 2020128429 A5 JP2020128429 A5 JP 2020128429A5 JP 2020096003 A JP2020096003 A JP 2020096003A JP 2020096003 A JP2020096003 A JP 2020096003A JP 2020128429 A5 JP2020128429 A5 JP 2020128429A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pharmaceutical tablet
- water
- pharmaceutical
- tablet according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 7
- 239000000654 additive Substances 0.000 claims 7
- 230000000996 additive effect Effects 0.000 claims 5
- 229960001518 levocarnitine Drugs 0.000 claims 5
- 239000000843 powder Substances 0.000 claims 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 239000011247 coating layer Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022000499A JP2022033292A (ja) | 2014-08-29 | 2022-01-05 | レボカルニチンを含有する医薬錠剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014176384 | 2014-08-29 | ||
| JP2014176384 | 2014-08-29 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015168835A Division JP2016050206A (ja) | 2014-08-29 | 2015-08-28 | レボカルニチンを含有する医薬錠剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022000499A Division JP2022033292A (ja) | 2014-08-29 | 2022-01-05 | レボカルニチンを含有する医薬錠剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020128429A JP2020128429A (ja) | 2020-08-27 |
| JP2020128429A5 true JP2020128429A5 (enExample) | 2020-10-08 |
| JP7005687B2 JP7005687B2 (ja) | 2022-01-21 |
Family
ID=55657970
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015168835A Pending JP2016050206A (ja) | 2014-08-29 | 2015-08-28 | レボカルニチンを含有する医薬錠剤 |
| JP2020096003A Active JP7005687B2 (ja) | 2014-08-29 | 2020-06-02 | レボカルニチンを含有する医薬錠剤 |
| JP2022000499A Pending JP2022033292A (ja) | 2014-08-29 | 2022-01-05 | レボカルニチンを含有する医薬錠剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015168835A Pending JP2016050206A (ja) | 2014-08-29 | 2015-08-28 | レボカルニチンを含有する医薬錠剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022000499A Pending JP2022033292A (ja) | 2014-08-29 | 2022-01-05 | レボカルニチンを含有する医薬錠剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (3) | JP2016050206A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6964876B2 (ja) * | 2017-11-27 | 2021-11-10 | 株式会社古川リサーチオフィス | オロット酸−カルニチン混合体粉体又はフマル酸−カルニチン混合体粉体の製造方法 |
| JP7541319B2 (ja) * | 2019-04-18 | 2024-08-28 | 共和薬品工業株式会社 | 吸湿性成分を含むコーティング錠 |
| JP7588973B2 (ja) * | 2019-06-24 | 2024-11-25 | 大塚製薬株式会社 | レボカルニチン含有錠剤 |
| JP7366612B2 (ja) * | 2019-07-09 | 2023-10-23 | 東和薬品株式会社 | レボカルニチンを含有する錠剤 |
| CN112826803B (zh) * | 2021-02-24 | 2024-01-19 | 东北制药集团沈阳第一制药有限公司 | 一种左卡尼汀片及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07103023B2 (ja) * | 1987-04-27 | 1995-11-08 | ア−ス製薬株式会社 | 尿素サイクル代謝異常症治療剤 |
| JP2005104972A (ja) * | 2003-09-08 | 2005-04-21 | Nof Corp | Ｌ−カルニチン圧縮成形体、及びその製造方法 |
| CN102038671B (zh) * | 2010-06-29 | 2012-07-04 | 辽宁思百得医药科技有限公司 | 包含左卡尼汀和羟苯磺酸盐的药物组合物 |
-
2015
- 2015-08-28 JP JP2015168835A patent/JP2016050206A/ja active Pending
-
2020
- 2020-06-02 JP JP2020096003A patent/JP7005687B2/ja active Active
-
2022
- 2022-01-05 JP JP2022000499A patent/JP2022033292A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020128429A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2017510602A5 (enExample) | ||
| JP2013010803A5 (enExample) | ||
| RU2019138248A (ru) | Фармацевтическая композиция для перорального введения, содержащая энзалутамид | |
| JP2015007131A5 (enExample) | ||
| AR070863A1 (es) | Preparacion solida de desintegracion oral y metodo para suprimir la ruptura de los granulos finos durante la produccion de un comprimido | |
| WO2014101986A8 (en) | Dry granulation process for producing tablet compositions of metformin and compositions thereof | |
| JP2017106010A5 (enExample) | ||
| JP2014122247A5 (ja) | β−クリプトキサンチンを有効成分とするペルオキシソーム増殖剤応答性受容体（ＰＰＡＲ）の活性化剤 | |
| JP2014080432A5 (enExample) | ||
| JP2016044170A5 (enExample) | ||
| FI3583943T3 (fi) | Farmaseuttinen koostumus | |
| PH12020551518A1 (en) | Pharmaceutical composition comprising meta arsenite and method of manufacture | |
| MX354454B (es) | Procedimiento de elaboracion de microcapsulas entericas de alginato por gelacion ionica que contienen diclofenac o una de sus sales y composicion farmaceutica multiparticulada que las contiene. | |
| JP2015129175A5 (enExample) | ||
| JP2015129124A5 (enExample) | ||
| JP2014062064A5 (enExample) | ||
| JP2010030903A5 (enExample) | ||
| EA033291B1 (ru) | Единица дозирования, содержащая рамиприл и бисопролола гемифумарат, способ ее получения и способ лечения гипертензии | |
| SI2805714T1 (en) | A stable pharmaceutical composition comprising amorphous rosuvastatin calcium | |
| JP2018095567A5 (enExample) | ||
| MX386908B (es) | Formulacion de liberacion modificada de naproxeno sodico. | |
| JP2015508805A5 (enExample) | ||
| JP2015183001A5 (enExample) |